General fitness, health and nutrition · Public discussion

Ultralente crystal size

Started by Jim Dumas · · Last activity · 52 posts · 1,503 views

Thread navigation

Jump through the discussion

Go to the original post, the replies on this page, or the latest preserved contribution.

Thread details

What we know about this thread

Original section
General fitness, health and nutrition
Published
7 April 2004
Last activity
17 April 2004
Original author
Jim Dumas
Posts
52
Discussion status
Public discussion
Total views
1,503
Views / 30 days
0

The navigation and discussion metadata provide context. Posts remain in their original chronological order.

Showing posts 1–20 of 52
Posts remain in their original chronological order.

Text size
  1. I've been reading Novo patents for crystal sizes. The most
    promising US patent is #2799622: "Process of Producing
    Insulin Crystals of Substantially Uniform Size and
    Compositions Thereof," 16 July, 1957.

    This patent provides an equation to estimate seed crystal
    requirements given seed crystal size, required finished
    crystal size and weight of insulin that will be crystalized.
    The examples focus on 30 micron required finished size and
    states it is possible to obtain 80-90% in the form of 28-36
    micron crystals. This diameter is the longest diagonal
    distance across the crystals. Assuming a normal (Gaussian)
    distribution, setting the mean to 32 microns and forcing the
    difference of integrals:

    int(28,infinity) - int(36, infinity) = 0.85 or 85% yield

    This gives a standard deviation of 2.75 microns in crystal
    size. So the mean+2SD=~37.5 or about 38 microns for the
    maximum crystal size in commercial ultralente. The lower
    size is probably 26 microns.

    This assumes a perfect seed size of 4 microns as recommended
    in the patent. If the manufacturer is sloppy then the sizes
    could be less uniform.

    In any case, this is very close to Michel's 40 micron
    number.

    This range of crystal sizes in ultralente could cause
    variable subcutaneous absorption characteristics. It also
    suggests there could be differences in crystal sizes between
    batches from the manufacturer (only Lilly these days).

    Novo patent US#2882202: "Insulin Crystal Preparations and
    Methods of Producting Them," 14 April, 1959; states 10
    micron crystals produce the same basal insulinemia effect
    (time course of action) as amorphous PZI in dog models.
    Crystal sizes of 25-100 microns have longer effects than PZI
    in dog models. This is an excellent benchmark to keep in
    mind as it probably set the goal for the 30 micron design
    size above.

    Food for thought,
    --
    Jim Dumas T1 4/86, background retinopathy, rarely
    hypoglycemic: <1/mo. lispro+R+U+NPH daily, moderate
    exercise, typically <6% HbA1c

  2. too much time on your hands, Jim?

    dave

    Jim Dumas said:

    I've been reading Novo patents for crystal sizes. The most
    promising US patent is #2799622: "Process of Producing
    Insulin Crystals of Substantially Uniform Size and
    Compositions Thereof," 16 July, 1957.

    This patent provides an equation to estimate seed crystal
    requirements given seed crystal size, required finished
    crystal size and weight of insulin that will be
    crystalized. The examples focus on 30 micron required
    finished size and states it is possible to obtain 80-90%
    in the form of 28-36 micron crystals. This diameter is the
    longest diagonal distance across the crystals. Assuming a
    normal (Gaussian) distribution, setting the mean to 32
    microns and forcing the difference of integrals:

    int(28,infinity) - int(36, infinity) = 0.85 or 85% yield

    This gives a standard deviation of 2.75 microns in crystal
    size. So the mean+2SD=~37.5 or about 38 microns for the
    maximum crystal size in commercial ultralente. The lower
    size is probably 26 microns.

    This assumes a perfect seed size of 4 microns as
    recommended in the patent. If the manufacturer is sloppy
    then the sizes could be less uniform.

    In any case, this is very close to Michel's 40
    micron number.

    This range of crystal sizes in ultralente could cause
    variable subcutaneous absorption characteristics. It
    also suggests there could be differences in crystal
    sizes between batches from the manufacturer (only Lilly
    these days).

    Novo patent US#2882202: "Insulin Crystal Preparations and
    Methods of Producting Them," 14 April, 1959; states 10
    micron crystals produce the same basal insulinemia effect
    (time course of action) as amorphous PZI in dog models.
    Crystal sizes of 25-100 microns have longer effects than
    PZI in dog models. This is an excellent benchmark to keep
    in mind as it probably set the goal for the 30 micron
    design size above.

    Food for thought,

  3. Bay Area Dave said:

    too much time on your hands, Jim?

    Not as much as you obviously have.
    --
    Jim Dumas T1 4/86, background retinopathy, rarely
    hypoglycemic: <1/mo. lispro+R+U+NPH daily, moderate
    exercise, typically <6% HbA1c

  4. how do you figure? my posts are short and to the point.
    little time spent! 🙂

    Jim Dumas said:
    Bay Area Dave said:

    too much time on your hands, Jim?

    Not as much as you obviously have.

  5. Bay Area Dave said:

    how do you figure?

    Easy. Your post was designed to cause trouble. Therefore,
    you have much more time on your hands than I do.

    Two years ago I posted to MHD that I was thinking about
    making my own ultralente rDNA insulin if Lilly discontinued
    UL (Google on "Michel: How to make UL?"😉. These patents
    describe various methods to produce insulin crystals and
    are in keeping with my interest in this area. Michel Martin
    had successfully done this with beef insulin but the
    equipment required was expensive. I think I can do this on
    the cheap. So the patent search is necessary to understand
    the prior art.

    In any case, I figure you're not interested UL and
    should nose out.
    --
    Jim Dumas T1 4/86, background retinopathy, rarely
    hypoglycemic: <1/mo. lispro+R+U+NPH daily, moderate
    exercise, typically <6% HbA1c

  6. cause trouble?? my, my you are awful touchy, Jim. neither of
    my 2 previous posts were rude. I was just teasing you.
    apparently you aren't amenable to teasing. I shall leave you
    to your studies and shall try to refrain from engaging you
    in the future.

    in fact, let's make it for sure--PLONK!

    Feel better?

    dave

    Jim Dumas said:
    Bay Area Dave said:

    how do you figure?

    Easy. Your post was designed to cause trouble. Therefore,
    you have much more time on your hands than I do.

    Two years ago I posted to MHD that I was thinking about
    making my own ultralente rDNA insulin if Lilly
    discontinued UL (Google on "Michel: How to make UL?"😉.
    These patents describe various methods to produce insulin
    crystals and are in keeping with my interest in this area.
    Michel Martin had successfully done this with beef insulin
    but the equipment required was expensive. I think I can do
    this on the cheap. So the patent search is necessary to
    understand the prior art.

    In any case, I figure you're not interested UL and should
    nose out.

  7. Bay Area Dave said:

    Feel better?

    Indeed I do. Thank God for minor miracles.
    --
    Jim Dumas T1 4/86, background retinopathy, rarely
    hypoglycemic: <1/mo. lispro+R+U+NPH daily, moderate
    exercise, typically <6% HbA1c

  8. Hey Dave, do not mess with the animal insulin people.

    Most of them are technically competent. Some people find
    that animal insulin works better for them. There is a
    serious threat to the supply.

    I found It did not work better for me but all diabetics are
    not the same. Jim Dumas has been an excellent source of
    information for me. I can say the same for Michael Martin.
    There are more issue to diabetes that the common items. Live
    and let live.

    I need all of the help I can get. Including you. Guy

    On Thu, 08 Apr 2004 01:53:38 GMT, Jim Dumas <j-

    [email protected]!mindspring.com said:
    Bay Area Dave said:

    Feel better?

    Indeed I do. Thank God for minor miracles.

  9. I wouldn't (and didn't) say that Jim didn't know his
    "technical stuff". I was commenting on the fact that he
    posted something that is over the heads of us mere
    mortals, but I didn't do it in a disrespectfully way. He
    took offense, unfortunately. Since he argued
    unsuccessfully with me ad infinitum in the recent past, I
    find it relevant to shield his posts from my eyes in order
    not to clutter the NG with endless arguing over fine
    points that neither will concede.

    My intention is to limit endless debate that won't solve
    anything. my opinion vs his opinion. it's fruitless.

    doesn't that sound reasonable to you, Guy?

    dave

    Guy said:

    Hey Dave, do not mess with the animal insulin people.

    Most of them are technically competent. Some people find
    that animal insulin works better for them. There is a
    serious threat to the supply.

    I found It did not work better for me but all diabetics
    are not the same. Jim Dumas has been an excellent source
    of information for me. I can say the same for Michael
    Martin. There are more issue to diabetes that the common
    items. Live and let live.

    I need all of the help I can get. Including you. Guy

    On Thu, 08 Apr 2004 01:53:38 GMT, Jim Dumas <j-

    [email protected]!mindspring.com said:
    Bay Area Dave said:

    Feel better?

    Indeed I do. Thank God for minor miracles.

  10. Bay Area Dave <[email hidden]> wrote on Thu, 08 Apr 2004 03:32:17 GMT:

    Quoted message said:

    I wouldn't (and didn't) say that Jim didn't know his
    "technical stuff". I was commenting on the fact that he
    posted something that is over the heads of us mere
    mortals, but I didn't do it in a disrespectfully way. He
    took offense, unfortunately.

    I found your first post disrespectful. Playfully
    intended perhaps, but somewhat ambiguous in tone. Jim's
    reply, objecting to that post was fully in order - not
    the only proper way to take your post, but a valid one,
    none the less.

    Your _second_ post, confirmed and anchored the disrespect
    which was only latent in your first, whatever the intent of
    that first might have been. A short, even lighthearted
    apology wouldn't have been out of place there.

    Quoted message said:

    Since he argued unsuccessfully with me ad infinitum in the
    recent past, I find it relevant to shield his posts from
    my eyes in order not to clutter the NG with endless
    arguing over fine points that neither will concede.

    Quoted message said:

    My intention is to limit endless debate that won't solve
    anything. my opinion vs his opinion. it's fruitless.

    However, your action seems almost optimally designed for the
    prolongation of bitter squabling.

    Let's not do this here. Please.

    Quoted message said:

    dave

    --
    Alan Mackenzie (Munich, Germany) Email: [email hidden]; to
    decode, wherever there is a repeated letter (like "aa"😉,
    remove half of them (leaving, say, "a"😉.

  11. In article <[email hidden]>,

    Bay Area Dave said:

    I wouldn't (and didn't) say that Jim didn't know his
    "technical stuff". I was commenting on the fact that he
    posted something that is over the heads of us mere mortals,

    It should not be over the head of anyone with a good enough
    education to be able to make intelligent decisions.

    --
    This address is for information only. I do not claim that
    these views are those of the Statistics Department or of
    Purdue University. Herman Rubin, Department of Statistics,
    Purdue University [email hidden] Phone: (765)494-
    6054 FAX: (765)494-0558

  12. this thread would have ended last night had you not
    interjected. while I appreciate your psychoanalytical
    skills, this thread is finito. Jim's response was uncalled
    for with respect to my FIRST post. we can either agree to
    disagree OR you can argue with yourself, as I'm D O N E
    arguing this thread.

    thanks for your cooperation.

    dave

    Alan Mackenzie said:

    Bay Area Dave <[email hidden]> wrote on Thu, 08 Apr 2004
    03:32:17 GMT:

    Quoted message said:

    I wouldn't (and didn't) say that Jim didn't know his
    "technical stuff". I was commenting on the fact that he
    posted something that is over the heads of us mere
    mortals, but I didn't do it in a disrespectfully way. He
    took offense, unfortunately.

    I found your first post disrespectful. Playfully
    intended perhaps, but somewhat ambiguous in tone. Jim's
    reply, objecting to that post was fully in order - not
    the only proper way to take your post, but a valid one,
    none the less.

    Your _second_ post, confirmed and anchored the disrespect
    which was only latent in your first, whatever the intent
    of that first might have been. A short, even lighthearted
    apology wouldn't have been out of place there.

    Quoted message said:

    Since he argued unsuccessfully with me ad infinitum in the
    recent past, I find it relevant to shield his posts from
    my eyes in order not to clutter the NG with endless
    arguing over fine points that neither will concede.

    Quoted message said:

    My intention is to limit endless debate that won't solve
    anything. my opinion vs his opinion. it's fruitless.

    However, your action seems almost optimally designed for
    the prolongation of bitter squabling.

    Let's not do this here. Please.

    Quoted message said:

    dave

  13. Jim Dumas said:

    I've been reading Novo patents for crystal sizes. The most
    promising US patent is #2799622: "Process of Producing
    Insulin Crystals of Substantially Uniform Size and
    Compositions Thereof," 16 July, 1957.

    This patent is an ultralente gold mine. The time to
    crystallize with constant stirring is 15-20 hours for seed
    crystals of 1-7 microns. It also states the design goal is
    for crystal sizes from 10-40 microns.

    So I'm revising my design requirements to a mean of 30
    microns. This gives a 2 micron standard deviation for the
    integral difference of:

    Gaussian integral(28 to infinity) - integral(36 to
    infinity) = 0.84

    or an 84% yield (80-90% req'd) for crystal sizes of 28-
    36 microns.

    Next, I will not filter my preparation but will accept
    Gaussian tails on both sides of the 30 micron average. This
    should produce 95% of the crystals between 26-34 microns
    (mean +/- 2SD). The integral difference for crystals between
    10 and 40 microns is 0.9999997! That is, most crystals are
    the correct size to give prolonged subcutaneous absorption
    without filtering small or large crystals out. The integral
    for 40 to infinity is
    2.87e-7 so there should be no crystals larger than 40
    microns in the preparation.

    The tricky part is getting the optimum 4 micron seed
    crystals. The next issue is the pH (5-7 required for
    crystallization). It will probably drop to 6 with the
    high zinc concentration. But Lantus is an acid pH so I
    don't think this is an issue for injecting subcutaneously
    (pain-wise).

    The basic idea is to take a 10 ml vial of rDNA Humulin R,
    add the correct number of sterile 4 micron seed crystals and
    zinc salt. Then use my BBQ rotor to tumble the mixture for a
    day at room temperature. Then remove excess fluid to achieve
    U-100 again. The zinc content may also have to be lowered by
    the same removal then add sterile distilled/deionized water.
    This will also bring the pH up closer to neutral. But I
    think this is possible with little expense in equipment.

    So how to get/make 4 micron seed crystals is the show
    stopper.
    --
    Jim Dumas T1 4/86, background retinopathy, rarely
    hypoglycemic: <1/mo. lispro+R+U+NPH daily, moderate
    exercise, typically <6% HbA1c

  14. On Thu, 08 Apr 2004 19:10:54 GMT, Jim Dumas

    [email protected]!mindspring.com said:

    The basic idea is to take a 10 ml vial of rDNA Humulin R,
    add the correct number of sterile 4 micron seed crystals
    and zinc salt. Then use my BBQ rotor to tumble the mixture
    for a day at room temperature. Then remove excess fluid to
    achieve U-100 again. The zinc content may also have to be
    lowered by the same removal then add sterile
    distilled/deionized water. This will also bring the pH up
    closer to neutral. But I think this is possible with little
    expense in equipment.

    So how to get/make 4 micron seed crystals is the show
    stopper.

    Are you actually considering making your own insulin? It's
    fun to play with statistics and bell curves, but making
    insulin is next to crazy. Suppose you make it, who will be
    the guinea pig for the first injection?

    _____________________________________________
    tcainternet.comindex.html Free
    Diabetic Software

  15. Jim Dumas said:

    I've been reading Novo patents for crystal sizes. The most
    promising US patent is #2799622: "Process of Producing
    Insulin Crystals of Substantially Uniform Size and
    Compositions Thereof," 16 July, 1957.

    This patent provides an equation to estimate seed crystal
    requirements given seed crystal size, required finished
    crystal size and weight of insulin that will be
    crystalized. The examples focus on 30 micron required
    finished size and states it is possible to obtain 80-90%
    in the form of 28-36 micron crystals. This diameter is the
    longest diagonal distance across the crystals. Assuming a
    normal (Gaussian) distribution, setting the mean to 32
    microns and forcing the difference of integrals:


    <snip>

    Quoted message said:

    In any case, this is very close to Michel's 40
    micron number.

    This range of crystal sizes in ultralente could cause
    variable subcutaneous absorption characteristics. It
    also suggests there could be differences in crystal
    sizes between batches from the manufacturer (only Lilly
    these days).


    <snip>

    another thought...

    almost everyone seems to think of Lente as an
    "intermediate" insulin

    nothing could be further from the truth!!!

    Lente is 70% UL

    there are at least 3 different companies (on the world
    market) who are still making various Lente insulins. 🙂

    if Novo still does Lente (i.e. "human"-L), that'd make 4

    bill t1 since '57, ex 8-yr pumper, pork/beef-L 2x,
    simple MDI/DAFNE

  16. Jim Dumas said:

    Two years ago I posted to MHD that I was thinking about
    making my own ultralente rDNA insulin if Lilly
    discontinued UL (Google on "Michel: How to make UL?"😉.
    These patents describe various methods to produce insulin
    crystals and are in keeping with my interest in this area.
    Michel Martin had successfully done this with beef insulin

    incorrect

    mickey found a way to make pork-SL (SemiLente) from pork-R

    he called it "quasi-Lente" 🙂

    fwiw, Novo's pork-R gave him better results than
    Lilly's pork-R

    i'd suggest you e-mail him

    this assumes that he's still alive now that he's on rDNA
    [censored]

    bill t1 since '57, pork/beef-L 2x, simple MDI/DAFNE

    Quoted message said:

    but the equipment required was expensive. I think I can do
    this on the cheap. So the patent search is necessary to
    understand the prior art.

    In any case, I figure you're not interested UL and should
    nose out.

  17. Hi_Therre said:

    Are you actually considering making your own insulin? It's
    fun to play with statistics and bell curves, but making
    insulin is next to crazy. Suppose you make it, who will be
    the guinea pig for the first injection?

    The issue is the loss of human rDNA ultralente from the US
    market. This has been expected for two years now. Novo
    discontinued human ultralente in the US a few years ago, but
    marketed it in Canada until recently (I think it may be
    discontinued in Canada, but not sure). My therapeutic goal
    is to stay with the human insulin molecule until hell
    freezes over. The only analogue I plan to use is Humalog,
    since it has not provoked an immune response from my body,
    (glucose disposal peaks in 1-2 hours as advertised by Lilly
    so no antibody binding delays).

    If UL is eventually discontinued in the US, then I will try
    to make my own for personal use. I plan to be the test
    subject and would probably buy a cheap microscope to do a QC
    check on crystal sizes for each batch.

    Note that Lilly mentions the possibility of adding zinc to
    current human rDNA ultralente insulin, to achieve longer
    action than beef ultralente. This was in patent number
    5534488 where some kit would be sold to pharmacies to mix at
    the pharmacy for patients that require longer insulin action
    than current UL provides. So this idea of mixing on demand
    has been explored by Lilly, at least.

    In my case, the kit would also include 4 micron seed
    crystals along with the zinc. Then slowly tumble it for 24
    hours to form the larger crystals. All I'm doing is taking
    the R hexamers and forming large crystals. So I'm not making
    the rDNA insulin, per se. I'm just recrystallizing it.

    And I don't think it's hard to do. But still researching
    the method,
    --
    Jim Dumas T1 4/86, background retinopathy, rarely
    hypoglycemic: <1/mo. lispro+R+U+NPH daily, moderate
    exercise, typically <6% HbA1c

  18. willbill said:

    incorrect

    mickey found a way to make pork-SL (SemiLente) from pork-R

    he called it "quasi-Lente" 🙂

    fwiw, Novo's pork-R gave him better results than
    Lilly's pork-R

    i'd suggest you e-mail him

    Thanks Bill,

    So Michel didn't find a way to make seed crystals. He added
    zinc without seed crystals and SL resulted.

    Good info. Guess I'll email him. Thanks,
    --
    Jim Dumas T1 4/86, background retinopathy, rarely
    hypoglycemic: <1/mo. lispro+R+U+NPH daily, moderate
    exercise, typically <6% HbA1c

  19. willbill said:

    Lente is 70% UL

    there are at least 3 different companies (on the world
    market) who are still making various Lente insulins. 🙂

    Agreed.

    Lente is a good substitute for UL. So this is another
    avenue. We have:

    CP Pharma Lilly USV-India

    Not sure about Novo's L.

    But if the R->UL works, then the FDA is out of the loop and
    the supplies are local. So this has merit in a pinch. It
    assumes R will always be available. This could be a problem
    as analogues continue to be developed.

    Lente is a good suggestion. Thanks,
    --
    Jim Dumas T1 4/86, background retinopathy, rarely
    hypoglycemic: <1/mo. lispro+R+U+NPH daily, moderate
    exercise, typically <6% HbA1c

  20. On Fri, 09 Apr 2004 01:01:23 GMT, Jim Dumas

    [email protected]!mindspring.com said:


    Lente is a good suggestion. Thanks,

    Jim,has any work been done on a capsule of insulin under
    pressure being fed through a capillary. I have seen
    applications where this principle was used for other things.
    With a long capillary the flow rate is almost constant over
    a wide range of pressures.

    Maybe a basal for a week before inserting of a new capsule.

    Or even go wilder and find a membrane that would respond to
    blood sugars. I would to hear about the results of any work
    in these areas.

    Guy

Active in the last 60 minutes

Active in this thread

0 users · 0 guests ·0 bots ·0 total

No signed-in users are active right now.

No known search crawlers active right now.